Spain - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale
Since 2014, Spain Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale rose 7.5% year on year. With €176,754,726.66 in 2019, the country was number 6 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Spain is overtaken by France, which was number 5 at €642,378,032.96 and is followed by Hungary with €123,176,988.66. Denmark topped the ranking with €3,801,340,964.3 in 2019, a decrease of 2.9% compared to 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.
Loading...
Date | Euros |
---|---|
2019 | 176,754,726.66 |
2018 | 176,338,057.00 |
2017 | 166,322,624.00 |
2016 | 153,995,200.00 |
2015 | 128,581,765.00 |
How does Spain rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?
# | 16 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
3,801,340,964.30 | 2019 | -2.9 % | +26.5 % | View data | |
2 |
#2
Belgium
|
1,624,727,500.00 | 2018 | +46.2 % | NA | View data | |
5 |
#5
France
|
642,378,032.96 | 2019 | +2.7 % | -2.6 % | View data | |
6 |
#6
Spain
|
176,754,726.66 | 2019 | +0.2 % | +7.5 % | View data | |
7 |
#7
Hungary
|
123,176,988.66 | 2019 | +7.5 % | +10.1 % | View data |